Managing Sleep-Wake Disorders

Circadian Rhythm Sleep-Wake Disorders

The American Academy of Sleep Medicine recommends melatonin receptor agonists as the first-line pharmacological treatment for circadian rhythm sleep-wake disorders, with melatonin administration timed appropriately based on the individual's circadian rhythm 1
Melatonin receptor agonists like tasimelteon are particularly effective for Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), especially in blind individuals 1
The American Academy of Sleep Medicine suggests evening light therapy for Advanced Sleep-Wake Phase Disorder (ASWPD) patients rather than pharmacological treatment 2, 3
Melatonin receptor agonists are effective for treating Irregular Sleep-Wake Rhythm Disorder (ISWRD) 1

The American Geriatrics Society recommends modafinil for improving wakefulness in adult patients with excessive sleepiness associated with narcolepsy, with a starting dose of 100 mg once upon awakening in the morning for elderly patients, which can be increased at weekly intervals as necessary 4
Typical doses of modafinil range from 200 to 400 mg per day 4

The American College of Clinical Pharmacology recommends eszopiclone (1-2 mg) as a first-line treatment for insomnia in elderly patients due to its efficacy in improving sleep onset and maintenance with minimal impact on sleep architecture 5
Ramelteon (8 mg) may be considered for patients with primarily sleep onset difficulties 5, 6
Elderly patients have reduced clearance of sedative-hypnotics and increased sensitivity to peak drug effects, requiring lower starting doses 5
The American Academy of Sleep Medicine suggests ramelteon for sleep onset insomnia in patients with addiction history 6

Maintaining stable bed times and rising times is recommended for managing sleep-wake disorders 6
Avoiding caffeine, nicotine, and alcohol is recommended for managing sleep-wake disorders 6
Limiting daytime napping to 30 minutes and avoiding napping after 2 pm is recommended for managing sleep-wake disorders 6

The American Geriatrics Society recommends more frequent follow-up when starting a medication or adjusting doses 4
Monitoring for adverse effects of stimulants, including hypertension, palpitations, arrhythmias, irritability, or behavioral manifestations, is necessary 4
Assessing functional ability due to residual sleepiness, as medications like modafinil generally improve but do not eliminate sleepiness, is necessary 4
The Epworth Sleepiness Scale (ESS) is a useful tool for monitoring subjective sleepiness and response to therapy 4

Benzodiazepines should be avoided in elderly patients due to increased risk of falls, cognitive impairment, and dependence 5
Sleep-promoting medications should be administered on an empty stomach to maximize effectiveness 5